“Adrenergic receptor autoantibodies”的意思、由来-开放百科全书

The adrenergic receptors (or adrenoreceptors) are a class of cell membrane-bound protein receptors throughout the body that are targets of the catecholamines, especially norepinephrine(or noradrenaline) and epinephrine (or adrenaline). The binding to these receptors by catecholamines will generally stimulate the sympathetic nervous system, the arm of the autonomic nervous system responsible for the fight-or-flight response.

The implications of high titers of these circulating antibodies are still being worked out and further investigated. There is compelling evidence that autoimmunity against this class of G protein-coupled receptors results in a variety of pathologies.

Circulating autoantibodies to adrenergic receptors have been identified in numerous heart diseases and cardiac symptoms. Laboratory models have revealed a mechanism by which adrenergic autoantibodies accomplish their effects on the cardiovascular system. “Beta1 autoantibodies trigger conformational changes in the receptor, attenuate receptor internalization. The combination of these two properties can result in bimodal effects on receptor activity that are meaningful for basal activity and chronotropic catecholamine responses of human cardiomyocytes.”^[1]

Beta-1 adrenergic receptors are the primary receptor of the heart and, therefore, autoantibodies to these receptors have been tied to many different heart diseases.

Autoantibodies to beta1-adrenergic receptors are linked to chronic heart failure.^[2]^[3] However, it has been proposed that both beta1-adrenergic receptor polymorphisms and autoantibodies could be working together in the development of chronic heart failure.^[4] Cardiomyopathy due to autoimmune dysregulation and production of autoantibodies has been seen in humans and reproduced in animal models.^[5] In rabbit models, increased expression of autoantibodies has been directly correlated with induction of atrial fibrillation.^[6]^[7] In canine models inoculated with adrenergic autoantibodies, it has been shown that beta blockers can negate certain cardiac arrhythmias.^[8] Refractory Hypertension associated with autoantibodies to beta1-adrenergic receptors has been documented in diabetic patients.^[9]

While the exact pathophysiology of Chagas disease is not completely understood, some models have shown that an overstimulation of the immune system causes production of adrenergic autoantibodies. Current research is trying to determine the exact role of these autoantibodies and whether they correlate with the symptomatology of Chagas disease.^[10]^[11]

The Heart Rhythm Institute at the University of Oklahoma points to an autoimmune basis in a condition that presents as chronic malfunction of the autonomic nervous system. The work of endocrinology labs have correlated autoantibodies to the beta-adrenergic receptors with Postural Orthostatic Tachycardia Syndrome (POTS).^[12]^[13]

Doctors compare the level of disability seen in POTS to the quality of life experienced in conditions like Chronic Obstructive Pulmonary Disease (COPD) or congestive heart failure. With the vast and vague symptomatology, and no previously known etiology, diagnosis and treatment proved elusive and challenging. The identification of these antibodies and the development of better testing provide hope for more targeted therapies and better treatment outcomes.

Experimental studies observed that activating autoantibodies to the beta1/2-adrenergic and M2 muscarinic receptors are associated with atrial tachyarrhythmias in patients with hyperthyroidism.^[16] Additional research into the prevalence of these biomarkers in Grave’s Disease (Grave’s Hyperthyroidism) showed facilitated triggering of pulmonary veins and atrial fibrillation.^[17]^[18]

Adrenergic autoantibodies have been linked to Buerger's disease (thromboangiitis obliterans).^[19] Buerger’s disease is a rare disease in which the arteries and veins in the arms and legs become inflamed, swell and can become blocked with blood clots, also known as thrombi.^[20]

References

1. ^{{Cite journal|last=Bornholz|first=Beatrice|last2=Weidtkamp-Peters|first2=Stefanie|last3=Schmitmeier|first3=Stephanie|last4=Seidel|first4=Claus A. M.|last5=Herda|first5=Lars R.|last6=Felix|first6=Stephan B.|last7=Lemoine|first7=Horst|last8=Hescheler|first8=Jürgen|last9=Nguemo|first9=Filomain|date=2013-03-01|title=Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization|pmc=3567785|journal=Cardiovascular Research|volume=97|issue=3|pages=472–480|doi=10.1093/cvr/cvs350|issn=0008-6363|pmid=23208588}}
2. ^{{Cite journal|last=Jahns|first=R.|last2=Boivin|first2=V.|last3=Siegmund|first3=C.|last4=Inselmann|first4=G.|last5=Lohse|first5=M. J.|last6=Boege|first6=F.|date=1999-02-09|title=Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure|pmid=9950662|journal=Circulation|volume=99|issue=5|pages=649–654|issn=0009-7322|doi=10.1161/01.CIR.99.5.649}}
3. ^{{Cite journal|last=Jahns|first=R.|last2=Boivin|first2=V.|last3=Siegmund|first3=C.|last4=Inselmann|first4=G.|last5=Lohse|first5=M. J.|last6=Boege|first6=F.|date=1999-02-09|title=Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure|pmid=9950662|journal=Circulation|volume=99|issue=5|pages=649–654|issn=0009-7322|doi=10.1161/01.CIR.99.5.649}}
4. ^{{Cite journal|last=Bornholz|first=Beatrice|last2=Hanzen|first2=Birgit|last3=Reinke|first3=Yvonne|last4=Felix|first4=Stephan B.|last5=Boege|first5=Fritz|title=Impact of common β1-adrenergic receptor polymorphisms on the interaction with agonistic autoantibodies in dilated cardiomyopathy|url=http://linkinghub.elsevier.com/retrieve/pii/S0167527316304430|journal=International Journal of Cardiology|volume=214|pages=83–85|doi=10.1016/j.ijcard.2016.03.032|pmid=27057984|date=July 2016}}
5. ^{{Cite journal|last=Yu|first=Xichun|last2=Patterson|first2=Eugene|last3=Stavrakis|first3=Stavros|last4=Huang|first4=Shijun|last5=De Aos|first5=Isabel|last6=Hamlett|first6=Sean|last7=Cunningham|first7=Madeleine W.|last8=Lazarra|first8=Ralph|last9=Kem|first9=David C.|date=2009-01-01|title=Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors|pmc=3116651|journal=Journal of the American Society of Hypertension : JASH|volume=3|issue=2|pages=133–140|doi=10.1016/j.jash.2008.10.004|issn=1933-1711|pmid=20409953}}
6. ^{{Cite journal|last=Li|first=Hongliang|last2=Murphy|first2=Taylor|last3=Zhang|first3=Ling|last4=Huang|first4=Bing|last5=Veitla|first5=Vineet|last6=Scherlag|first6=Benjamin J.|last7=Kem|first7=David C.|last8=Yu|first8=Xichun|date=2015-10-30|title=β1-Adrenergic and M2 Muscarinic Autoantibodies and Thyroid Hormone Facilitate Induction of Atrial Fibrillation in Male Rabbits|journal=Endocrinology|volume=157|issue=1|pages=16–22|doi=10.1210/en.2015-1655|pmid=26517045|issn=0013-7227}}
7. ^{{Cite journal|last=Stavrakis|first=Stavros|last2=Yu|first2=Xichun|last3=Patterson|first3=Eugene|last4=Huang|first4=Shijun|last5=Hamlett|first5=Sean R.|last6=Chalmers|first6=Laura|last7=Pappy|first7=Reji|last8=Cunningham|first8=Madeleine W.|last9=Morshed|first9=Syed A.|date=2009-09-29|title=Activating autoantibodies to the beta1-adrenergic and M2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism|pmc=2801559|journal=Journal of the American College of Cardiology|volume=54|issue=14|pages=1309–1316|doi=10.1016/j.jacc.2009.07.015|issn=0735-1097|pmid=19778674}}
8. ^{{Cite journal|last=Yu|first=Xichun|last2=Patterson|first2=Eugene|last3=Stavrakis|first3=Stavros|last4=Huang|first4=Shijun|last5=Aos|first5=Isabel De|last6=Hamlett|first6=Sean|last7=Cunningham|first7=Madeleine W.|last8=Lazarra|first8=Ralph|last9=Kem|first9=David C.|title=Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors|url=http://linkinghub.elsevier.com/retrieve/pii/S1933171108001861|journal=Journal of the American Society of Hypertension|volume=3|issue=2|pages=133–140|doi=10.1016/j.jash.2008.10.004|pmc=3116651|pmid=20409953|date=March 2009}}
9. ^{{Cite journal|last=Zhao|first=Lin-shuang|last2=Liao|first2=Yu-hua|last3=Xiang|first3=Guang-da|last4=Wang|first4=Min|last5=Zhou|first5=Zi-hua|last6=Hou|first6=Jie|last7=Le|first7=Ling|last8=Xu|first8=Lin|date=2006-05-01|title=[Autoantibodies against beta1 and M2 receptor in diabetic patients with refractory hypertension]|pmid=16776952|journal=Zhonghua Xin Xue Guan Bing Za Zhi|volume=34|issue=5|pages=407–410|issn=0253-3758}}
10. ^{{Cite journal|last=Soares|first=Milena B. P.|last2=Pontes-De-Carvalho|first2=Lain|last3=Ribeiro-Dos-Santos|first3=Ricardo|title=The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet|url=http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0001-37652001000400008&lng=en&nrm=iso&tlng=en|journal=Anais da Academia Brasileira de Ciências|volume=73|issue=4|pages=547–559|doi=10.1590/S0001-37652001000400008|issn=0001-3765|date=December 2001}}
11. ^{{Cite journal|last=Talvani|first=Andre|last2=Rocha|first2=Manoel O. C.|last3=Ribeiro|first3=Antonio L.|last4=Borda|first4=Enri|last5=Sterin-Borda|first5=Leonor|last6=Teixeira|first6=Mauro M.|date=2006-08-01|title=Levels of anti-M2 and anti-β1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease|url=http://www.sciencedirect.com/science/article/pii/S1286457906002371|journal=Microbes and Infection|volume=8|issue=9–10|pages=2459–2464|doi=10.1016/j.micinf.2006.06.006|pmid=16963301}}
12. ^{{Cite journal|last=Yu|first=Xichun|last2=Stavrakis|first2=Stavros|last3=Hill|first3=Michael A.|last4=Huang|first4=Shijun|last5=Reim|first5=Sean|last6=Li|first6=Hongliang|last7=Khan|first7=Muneer|last8=Hamlett|first8=Sean|last9=Cunningham|first9=Madeleine W.|date=2012-01-01|title=Autoantibody Activation of Beta-Adrenergic and Muscarinic Receptors Contributes to an "Autoimmune" Orthostatic Hypotension|pmc=3259269|journal=Journal of the American Society of Hypertension|volume=6|issue=1|pages=40–47|doi=10.1016/j.jash.2011.10.003|issn=1933-1711|pmid=22130180}}
13. ^{{Cite journal|last=Li|first=Hongliang|last2=Kem|first2=David C.|last3=Reim|first3=Sean|last4=Khan|first4=Muneer|last5=Vanderlinde-Wood|first5=Megan|last6=Zillner|first6=Caitlin|last7=Collier|first7=Daniel|last8=Liles|first8=Campbell|last9=Hill|first9=Michael A.|date=2012-02-01|title=AGONISTIC AUTOANTIBODIES AS VASODILATORS IN ORTHOSTATIC HYPOTENSION: A NEW MECHANISM|pmc=3275920|journal=Hypertension|volume=59|issue=2|pages=402–408|doi=10.1161/HYPERTENSIONAHA.111.184937|issn=0194-911X|pmid=22215709}}
14. ^{{Cite web|url=http://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/basics/definition/con-20022009|title=Chronic fatigue syndrome - Mayo Clinic|website=www.mayoclinic.org|access-date=2016-09-24}}
15. ^{{Cite web|url=http://www.mayoclinic.org/diseases-conditions/chronic-fatigue-syndrome/basics/definition/con-20022009|title=Chronic fatigue syndrome - Mayo Clinic|website=www.mayoclinic.org|access-date=2016-09-24}}
16. ^{{Cite journal|last=Galloway|first=Allison|last2=Li|first2=Hongliang|last3=Vanderlinde-Wood|first3=Megan|last4=Khan|first4=Muneer|last5=Benbrook|first5=Alexandria|last6=Liles|first6=Campbell|last7=Zillner|first7=Caitlin|last8=Rao|first8=Veitla|last9=Cunningham|first9=Madeleine W.|date=2014-12-11|title=Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism|journal=Endocrine|language=en|volume=49|issue=2|pages=457–463|doi=10.1007/s12020-014-0495-4|pmid=25500789|pmc=5810549|issn=1355-008X}}
17. ^{{Cite journal|last=Stavrakis|first=Stavros|last2=Yu|first2=Xichun|last3=Huang|first3=Shijun|last4=Cunningham|first4=Madeleine W.|last5=Kem|first5=David C.|last6=Patterson|first6=Eugene|date=2009-11-03|title=Abstract 2616: Facilitation of Triggered Firing in Superfused Canine Pulmonary Veins by Activating Antibodies to Beta Adrenergic and Muscarinic Receptors in Serum From Patients With Graves' Disease|url=http://circ.ahajournals.org/content/120/Suppl_18/S664.4|journal=Circulation|language=en|volume=120|issue=Suppl 18|pages=S664–S665|issn=0009-7322}}
18. ^{{Cite journal|last=Stavrakis|first=Stavros|last2=Yu|first2=Xichun|last3=Patterson|first3=Eugene|last4=Huang|first4=Shijun|last5=Hamlett|first5=Sean R.|last6=Chalmers|first6=Laura|last7=Pappy|first7=Reji|last8=Cunningham|first8=Madeleine W.|last9=Morshed|first9=Syed A.|date=2009-09-29|title=Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism|pmid=19778674|journal=Journal of the American College of Cardiology|volume=54|issue=14|pages=1309–1316|doi=10.1016/j.jacc.2009.07.015|issn=1558-3597|pmc=2801559}}
19. ^{{Cite journal|last=Klein-Weigel|first=Peter F.|last2=Bimmler|first2=Marion|last3=Hempel|first3=Petra|last4=Schöpp|first4=Sebastian|last5=Dreusicke|first5=Siegrid|last6=Valerius|first6=Jana|last7=Bohlen|first7=Anne|last8=Boehnlein|first8=Joana M.|last9=Bestler|first9=Daniel|date=2014-09-01|title=G-protein coupled receptor auto-antibodies in thromboangiitis obliterans (Buerger's disease) and their removal by immunoadsorption|pmid=25147011|journal=VASA. Zeitschrift für Gefässkrankheiten|volume=43|issue=5|pages=347–352|doi=10.1024/0301-1526/a000372|issn=0301-1526}}
20. ^{{Cite web|url=http://www.mayoclinic.org/diseases-conditions/buergers-disease/home/ovc-20179160|title=Overview - Buerger's disease - Mayo Clinic|website=www.mayoclinic.org|access-date=2016-09-24}}